Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
about
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case reportThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyDevelopment of a Cancer Treatment with the Concomitant Use of Low-Intensity Ultrasound: Entering the Age of Simultaneous Diagnosis and Treatment.Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.
P2860
Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@ast
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@en
type
label
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@ast
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@en
prefLabel
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@ast
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@en
P2093
P2860
P1433
P1476
Metronomic doxifluridine chemo ...... ine carcinosarcoma xenografts.
@en
P2093
Batsuren Choijamts
Kyoko Nakajima
Kyoko Shirota
Makoto Emoto
Shigenori Ogata
Shingo Miyamoto
Tatsuhiko Kawarabayashi
Yasuko Naganuma
P2860
P304
P356
10.1111/J.1349-7006.2011.01998.X
P577
2011-07-03T00:00:00Z